• Start
  • Cancer
  • Technology
    • Technology
    • Human Scaffolds
    • 3D Synthetic Scaffolds
  • Products & Services
  • Pipeline
  • News
  • Publications
  • Partners & Customers
  • About
Curing cancer by generating precision medicine Curing cancer by generating precision medicine Curing cancer by generating precision medicine Curing cancer by generating precision medicine
  • Start
  • Cancer
  • Technology
    • Technology
    • Human Scaffolds
    • 3D Synthetic Scaffolds
  • Products & Services
  • Pipeline
  • News
  • Publications
  • Partners & Customers
  • About

Archives

Monthly Archive for: "December, 2023"
Home » Archives for December 2023
13. Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features
0
By master
In Publication
Posted December 20, 2023

13. Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features

In this important publication, PDSs from 78 breast cancer samples with known patient outcomes, were prepared and repopulated with donor breast cancer cell lines, followed by treatment with [...]

READ MORE
12. Interleukin-6 Induces Stem Cell Propagation through Liaison with the Sortilin-Progranulin Axis in Breast Cancer
0
By master
In Publication
Posted December 8, 2023

12. Interleukin-6 Induces Stem Cell Propagation through Liaison with the Sortilin-Progranulin Axis in Breast Cancer

In this article, a novel cancer stem cell activating mechanism was described, mediated by progranulin and IL-6 secretion through activation of the receptor sortilin. Significant correlations were [...]

READ MORE
Recent Posts
  • Business Developer
    Business Developer
    May 1, 2024
  • Iscaffpharma’s first patent issued by the United States Patent and Trademark Office
    Iscaffpharma’s first patent issued by the United States Patent and Trademark Office
    January 26, 2024
  • SLAS honors Per Setterberg as fellow member
    SLAS honors Per Setterberg as fellow member
    October 19, 2023
Recent Publications
  • 17. Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells
    17. Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells
    December 16, 2024
  • 16. Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development
    16. Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development
    April 26, 2024
  • 15. Proteomics of cell-free breast cancer scaffolds identify clinically relevant imprinted proteins and cancer-progressing properties
    15. Proteomics of cell-free breast cancer scaffolds identify clinically relevant imprinted proteins and cancer-progressing properties
    April 4, 2024
Contact us
  • Org nr: 559120-9753
  • Iscaff Pharma AB
    Erik Dahlbergsgatan 11A
    411 26 Gothenburg
    Sweden
  • contact@iscaffpharma.com
Copyright All Rights Reserved © 2023
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt